Caribou Biosciences, Inc. (CRBU)
0.2843
-0.03
(-8.44%)
USD |
NASDAQ |
Nov 20, 16:00
0.2843
0.00 (0.00%)
After-Hours: 20:00
Caribou Biosciences Price to Book Value : 0.4008 for Nov. 20, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2026 | 0.4008 |
| November 19, 2026 | 0.4377 |
| November 18, 2026 | 0.4597 |
| November 17, 2026 | 0.4803 |
| November 16, 2026 | 0.4974 |
| November 13, 2026 | 0.5102 |
| November 12, 2026 | 0.536 |
| November 11, 2026 | 0.5508 |
| November 10, 2026 | 0.5786 |
| November 09, 2026 | 0.5918 |
| November 06, 2026 | 0.6326 |
| November 05, 2026 | 0.5813 |
| November 04, 2026 | 0.6265 |
| November 03, 2026 | 0.6477 |
| November 02, 2026 | 0.6202 |
| October 30, 2026 | 0.5966 |
| October 29, 2026 | 0.6274 |
| October 28, 2026 | 0.69 |
| October 27, 2026 | 0.6495 |
| October 26, 2026 | 0.6939 |
| October 23, 2026 | 0.7511 |
| October 22, 2026 | 0.7895 |
| October 21, 2026 | 0.7675 |
| October 20, 2026 | 0.7317 |
| October 19, 2026 | 0.6541 |
| Date | Value |
|---|---|
| October 16, 2026 | 0.6625 |
| October 15, 2026 | 0.6551 |
| October 14, 2026 | 0.6486 |
| October 13, 2026 | 0.6626 |
| October 12, 2026 | 0.7005 |
| October 09, 2026 | 0.6488 |
| October 08, 2026 | 0.6784 |
| October 07, 2026 | 0.8704 |
| October 06, 2026 | 1.600 |
| October 05, 2026 | 1.678 |
| October 02, 2026 | 1.72 |
| October 01, 2026 | 1.72 |
| September 30, 2026 | 1.790 |
| September 29, 2026 | 1.340 |
| September 28, 2026 | 1.329 |
| September 25, 2026 | 1.340 |
| September 24, 2026 | 1.351 |
| September 23, 2026 | 1.394 |
| September 22, 2026 | 1.448 |
| September 21, 2026 | 1.405 |
| September 18, 2026 | 1.405 |
| September 17, 2026 | 1.415 |
| September 16, 2026 | 1.351 |
| September 15, 2026 | 1.372 |
| September 14, 2026 | 1.394 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Anavex Life Sciences Corp. | 0.4876 |
| Vaxcyte, Inc. | 3.322 |
| Foghorn Therapeutics, Inc. | -- |
| Bolt Biotherapeutics, Inc. | 1.236 |
| Connect Biopharma Holdings Ltd. | 2.978 |
Price to Book Value Related Metrics
| PS Ratio | 3.002 |
| Price | 0.2843 |
| Earnings Yield | -362.2% |
| Market Cap | 30.71M |